How to deal with influenza?

BMJ

Volumn 329, Issue 7467, 2004, Pages 633-634

  Jefferson, Tom ^a  

^a Cochrane Vaccines Field ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; ANTIVIRUS AGENT; OSELTAMIVIR; RIMANTADINE; SIALIDASE INHIBITOR; ZANAMIVIR;

ADULT; CHILD; COST EFFECTIVENESS ANALYSIS; DRUG COST; EDITORIAL; HUMAN; IMMUNOASSAY; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS A; INFLUENZA VIRUS B; LABORATORY DIAGNOSIS; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; VIRUS INFECTION; EPIDEMIC; NOTE;

ANTIVIRAL AGENTS; DISEASE OUTBREAKS; HUMANS; INFLUENZA A VIRUS; INFLUENZA B VIRUS; INFLUENZA, HUMAN;

EID: 4644297524     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.329.7467.633     Document Type: Editorial

References (12)

1. Nicholson KG, Kent J, Hammersley V, Cancio E. Acute viral infections of upper respiratory tract in elderly people living in the community: comparative, prospective, population based study of disease burden. BMJ 1997; 315: 1060–4.
2. Makela MJ, Puhakka T, Ruuskanen O, Leinonen M, Saikku P, Kimpimaki M, et al. Viruses and bacteria in the aetiology of the common cold. J Clin Microbiol 1998; 36: 539–42.
3. Zambon MC, Stockton JD, Clewley JC, Zambon MC, Fleming DM. Contribution of influenza and respiratory syncytial virus to community cases of influenza-like illness: an observational study. Lancet 2001; 358: 1410–6.
4. Demicheli V, Rivetti D, Deeks JJ, Jefferson TO. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev 2004; 3: CD001269.
5. Wilkinson P, Pattenden S, Armstrong B, Fletcher A, Kovats R, Mangtani P, et al. Vulnerability to winter mortality in elderly people in Britain: population based study. BMJ 2004; 329: 647–51.
6. Jefferson T, Deeks JJ, Demicheli V, Rivetti D, Rudin M. Amantadine and rimantadine for preventing and treating influenza A in adults. Cochrane Database Syst Rev 2004; 3: CD001169.
7. Cooper NJ, Sutton AJ, Abrams KR, Wailoo A, Turner D, Nicholson KG, et al. Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials. BMJ 2003; 326: 1235–40.
8. Jefferson T, Demicheli V, Deeks JJ, Rivetti D. Neuraminidase inhibitors for preventing and treating influenza in healthy adults. Cochrane Database Syst Rev 2000(2): 001265.
9. Harling R, Hayward A, Watson JM. Implications of the incidence of influenza-like illness in nursing homes for influenza chemoprophylaxis: descriptive study. BMJ 2004; 329: 663–4.
10. Matheson NJ, Symmonds-Abrahams M, Sheikh A, Shepperd S, Harnden A. Neuraminidase inhibitors for preventing and treating influenza in children. Cochrane Database Syst Rev 2003(3): 002744.
11. Kiso M, Mitamura K, Sakai-Tagawa Y, Shiraishi K, Kawakami C, Kimura K, et al. Resistant influenza A viruses in children treated with oseltamivir: descriptive study. Lancet 2004; 364: 759–65.
12. Zambon M, Hays J, Webster A, Newman R, Keene O. Diagnosis of influenza in the community: relationship of clinical diagnosis to confirmed virological, serologic, or molecular detection of influenza. Arch Intern Med 2001; 161: 2116–22.